PlainPill

Cyanidin 3-Glucoside

People mainly take Cyanidin 3-Glucoside for performance, recovery, pain & inflammation. Based on 4 first-hand reports and 5 meta-analyses & systematic reviews in the medical literature. Ranked #775 of 1,974 overall.

21
User score
Mostly positive
50% positive0% mixed0% negative50% unclear

Of reports that state an outcome, 100% are positive.

Clinical research
AStrong research base
5
meta-analyses
11
RCTs
1,078
papers

What Cyanidin 3-Glucoside does, according to users

Of the people who reported each effect, the share who said it got better.

What the research says

Systematic reviews and meta-analyses from PubMed, with their published conclusions.

AStrong research base

3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found.

F1000Res · 2023 · Meta-analysis / systematic review
Benefit of Asian pigmented rice bioactive compound and its implication in breast cancer: a systematic review

Conclusion: The pigmented rice is mainly black, red, and dark purple rice, and contains a variety of peonidin-3-glucoside, cyanidin-3-glucoside, γ-oryzanol, γ-tocotrienol, proanthocyanidin, cinnamic acid, and anthocyanins that may act as pro-apoptotic, anti-proliferative, and anti-metastasis of the breast cancer cells. Conclusion: Pigmented rice is a beneficial food which possessed bioactive compounds that may have significant potential concerning a breast cancer.

PubMed 37854873 ↗
J Nutr · 2026 · Meta-analysis / systematic review
Antidiabetic Effect of Cyanidin-3-Glucoside: A Systematic Review of Animal Studies

Conclusion: C3G shows considerable promise as an antidiabetic agent as it improved glucose, insulin, and HbA1c concentrations in animal models of diabetes. Given these encouraging findings, there is a need for more robust clinical trials to validate its antidiabetic effect and assess its superiority, inferiority, or otherwise to standard antidiabetic agents. This trial was registered at PROSPERO as CRD420251078672.

PubMed 41371544 ↗

Dosage people report

As stated by users — not a recommendation. Follow the label or your doctor.

No doses stated in the reports so far.

Reported side effects

How often each side effect came up across all reports.

No side effects reported so far.

What users say

Verbatim quotes, shortened only — each links to the original discussion.

“This simple compound in a sufficient dosage is straight-up life changing. I've been taking it for years and completely changed my body composition”
Source discussion ↗
“Looking forward to trying this one alongside Epicatechin”
Source discussion ↗
“when I don't use C3G, I always have insane stomach pain.”
Source discussion ↗
Top discussions (3)

Other options for performance

User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 2, 2026. How we rate